BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780)

South Korea · Delayed Price · Currency is KRW

3,275.00

-75.00 (-2.24%)

Aug 12, 2026, 3:30 PM KST

BCWORLD PHARM. Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	79,812	75,800	74,814	75,111	72,703	62,079
Revenue Growth	7.37%	1.32%	-0.40%	3.31%	17.11%	8.85%
Gross Profit	31,886	30,541	28,012	31,876	27,206	19,931
Operating Income	4,498	1,997	1,500	6,365	1,862	-1,534
Net Income	-2,510	-4,897	-4,433	2,634	281.3	-1,843
Earnings Per Share	-270.07	-527.02	-478.00	257.95	27.28	-178.39
EPS Growth	-	-	-	845.59%	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	4,451	6,811	7,911	11,166	8,058	4,503
Total Debt	87,332	87,165	88,954	91,841	94,255	89,021
Net Cash (Debt)	-82,881	-80,354	-81,043	-80,675	-86,197	-84,518
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-8919.60	-8648.57	-8739.62	-7901.05	-8359.02	-8180.51

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	2,170	5,577	4,042	10,938	6,883	-619.83
Capital Expenditures	-4,857	-3,988	-2,398	-2,577	-6,217	-17,444
Free Cash Flow	-2,687	1,589	1,644	8,361	666.21	-18,064
Free Cash Flow Growth	-	-3.36%	-80.33%	1154.97%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	39.95%	40.29%	37.44%	42.44%	37.42%	32.10%
Operating Margin	5.63%	2.63%	2.00%	8.47%	2.56%	-2.47%
Pretax Margin	0.68%	-2.92%	-3.70%	1.61%	-2.09%	-4.73%
Profit Margin	-3.14%	-6.46%	-5.92%	3.51%	0.39%	-2.97%
FCF Margin	-3.37%	2.10%	2.20%	11.13%	0.92%	-29.10%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	90.909	-	-	-	-	-
Dividend Per Share Growth	10.00%	-	-	-	-	-
Dividend Yield	2.71%	-	-	-	-	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	20.70	254.09	-
P/FCF Ratio	-	32.19	26.36	6.52	107.29	-
PS Ratio	0.43	0.68	0.58	0.73	0.98	2.18